Trials / Terminated
TerminatedNCT00179582
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS
Detailed description
The study will evaluate 2 doses of VSL#3 and placebo over a 4 week period in patients presenting with diarrhea predominant IBS symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VSL#3 |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2005-09-16
- Last updated
- 2019-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00179582. Inclusion in this directory is not an endorsement.